Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2019

17.05.2019 | Original Article

Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells

verfasst von: Fei Ma, Bin Zhang, Sheqing Ji, Hongtao Hu, Ye Kong, Yawei Hua, Suxia Luo

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Gastric cancer (GC) is one of the most common causes of cancer death. Hypoxia is an important property of the tumor microenvironment of GC. Increasing evidence demonstrates that tumor-associated macrophages are related to the metastasis of GC, while the precise mechanism of how hypoxic macrophages affect tumor progression is still not fully understood.

Aims

To examine whether the mediators released from hypoxic macrophages contribute to the invasion and proliferation of GC cells.

Methods

Cell Counting Kit-8 was utilized to determine the proliferation of SGC7901 and MKN45 cells. The invasion of SGC7901 and MKN45 cells was measured by transwell invasion assay. Expression of VEGF mRNA in THP-1-derived macrophages was determined by RT-PCR, and protein level of VEGF in the culture medium was detected by ELISA.

Results

The proliferation and invasion of SGC7901 and MKN45 cells were dramatically increased after treatment with conditioned medium (CM) collected from THP-1-derived macrophages under hypoxia (H-CM), and the phosphorylation of Akt and p38 in SGC7901 and MKN45 cells was also up-regulated by H-CM stimulation. Notably, blockage of PI3K-Akt or p38 MAP kinase abolished the effects of H-CM on the proliferation and invasion of SGC7901 and MKN45 cells. Furthermore, VEGF was increased in macrophages after hypoxia and administration with nintedanib, an inhibitor of VEGFR, significantly decreases the phosphorylation of Akt and p38, as well as the proliferation and invasion of SGC7901 and MKN45 cells in response to H-CM.

Conclusions

Our findings suggest that hypoxia-injured macrophages contribute to the proliferation and invasion of GC cells through the release of mediators such as VEGF.
Literatur
1.
Zurück zum Zitat Suganuma M, Watanabe T, Yamaguchi K, et al. Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett. 2012;322:133–138.CrossRef Suganuma M, Watanabe T, Yamaguchi K, et al. Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett. 2012;322:133–138.CrossRef
2.
Zurück zum Zitat Otto C, Kaemmerer U, Illert B, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122.CrossRef Otto C, Kaemmerer U, Illert B, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122.CrossRef
3.
Zurück zum Zitat Wessler S, Krisch LM, Elmer DP, Aberger F. From inflammation to gastric cancer—the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal. 2017;15:15.CrossRef Wessler S, Krisch LM, Elmer DP, Aberger F. From inflammation to gastric cancer—the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal. 2017;15:15.CrossRef
4.
Zurück zum Zitat Cao Y, Bao S, Yang W, et al. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr Res. 2014;34:1066–1074.CrossRef Cao Y, Bao S, Yang W, et al. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr Res. 2014;34:1066–1074.CrossRef
5.
Zurück zum Zitat Kamate C, Baloul S, Grootenboer S, et al. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences. Int J Cancer. 2002;100:571–579.CrossRef Kamate C, Baloul S, Grootenboer S, et al. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences. Int J Cancer. 2002;100:571–579.CrossRef
6.
Zurück zum Zitat Noda S, Yashiro M, Nshii T, Hirakawa K. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer. 2010;46:995–1005.CrossRef Noda S, Yashiro M, Nshii T, Hirakawa K. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer. 2010;46:995–1005.CrossRef
7.
Zurück zum Zitat Liu L, Sun L, Zhao P, et al. Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor. Cancer Sci. 2010;101:1653–1660.CrossRef Liu L, Sun L, Zhao P, et al. Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor. Cancer Sci. 2010;101:1653–1660.CrossRef
8.
Zurück zum Zitat Shen Z, Kauttu T, Seppanen H, et al. Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro. Acta Oncol. 2013;52:852–860.CrossRef Shen Z, Kauttu T, Seppanen H, et al. Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro. Acta Oncol. 2013;52:852–860.CrossRef
9.
Zurück zum Zitat Guleng B, Han J, Yang JQ, et al. TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells. Mol Biol Rep. 2012;39:4127–4134.CrossRef Guleng B, Han J, Yang JQ, et al. TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells. Mol Biol Rep. 2012;39:4127–4134.CrossRef
10.
Zurück zum Zitat Bilgic CI, Tez M. Serum VEGF levels in gastric cancer patients: correlation with clinicopathological parameters. Turk J Med Sci. 2015;45:112–117.CrossRef Bilgic CI, Tez M. Serum VEGF levels in gastric cancer patients: correlation with clinicopathological parameters. Turk J Med Sci. 2015;45:112–117.CrossRef
11.
Zurück zum Zitat Ozdemir F, Akdogan R, Aydin F, et al. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer. J Exp Clin Cancer Res. 2006;25:83–88.PubMed Ozdemir F, Akdogan R, Aydin F, et al. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer. J Exp Clin Cancer Res. 2006;25:83–88.PubMed
12.
Zurück zum Zitat Roukos DH, Liakakos T, Karatzas G, Kappas AM. Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer? Nat Clin Pract Oncol. 2006;3:418–419.CrossRef Roukos DH, Liakakos T, Karatzas G, Kappas AM. Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer? Nat Clin Pract Oncol. 2006;3:418–419.CrossRef
13.
Zurück zum Zitat Abdel-Rahman O. Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: preclinical and clinical aspects. Crit Rev Oncol Hematol. 2015;93:18–27.CrossRef Abdel-Rahman O. Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: preclinical and clinical aspects. Crit Rev Oncol Hematol. 2015;93:18–27.CrossRef
14.
Zurück zum Zitat Ayremlou N, Mozdarani H, Mowla SJ, Delavari A. Increased levels of serum and tissue miR-107 in human gastric cancer: correlation with tumor hypoxia. Cancer Biomark. 2015;15:851–860.CrossRef Ayremlou N, Mozdarani H, Mowla SJ, Delavari A. Increased levels of serum and tissue miR-107 in human gastric cancer: correlation with tumor hypoxia. Cancer Biomark. 2015;15:851–860.CrossRef
15.
Zurück zum Zitat Grimshaw MJ, Balkwill FR. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation—a potential mechanism. Eur J Immunol. 2001;31:480–489.CrossRef Grimshaw MJ, Balkwill FR. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation—a potential mechanism. Eur J Immunol. 2001;31:480–489.CrossRef
16.
Zurück zum Zitat Egners A, Erdem M, Cramer T. The response of macrophages and neutrophils to hypoxia in the context of cancer and other inflammatory diseases. Mediators Inflamm. 2016;2016:2053646.CrossRef Egners A, Erdem M, Cramer T. The response of macrophages and neutrophils to hypoxia in the context of cancer and other inflammatory diseases. Mediators Inflamm. 2016;2016:2053646.CrossRef
17.
Zurück zum Zitat Griffiths L, Binley K, Iqball S, et al. The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 2000;7:255–262.CrossRef Griffiths L, Binley K, Iqball S, et al. The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 2000;7:255–262.CrossRef
18.
Zurück zum Zitat Wu MH, Lee WJ, Hua KT, et al. Macrophage infiltration induces gastric cancer invasiveness by activating the beta-catenin pathway. PLoS ONE. 2015;10:e0134122.CrossRef Wu MH, Lee WJ, Hua KT, et al. Macrophage infiltration induces gastric cancer invasiveness by activating the beta-catenin pathway. PLoS ONE. 2015;10:e0134122.CrossRef
19.
Zurück zum Zitat Zhang WJ, Chen C, Zhou ZH, et al. Hypoxia-inducible factor-1 alpha correlates with tumor-associated macrophages infiltration, influences survival of gastric cancer patients. J Cancer. 2017;8:1818–1825.CrossRef Zhang WJ, Chen C, Zhou ZH, et al. Hypoxia-inducible factor-1 alpha correlates with tumor-associated macrophages infiltration, influences survival of gastric cancer patients. J Cancer. 2017;8:1818–1825.CrossRef
20.
Zurück zum Zitat Zhou H, Wu J, Wang T, et al. CXCL10/CXCR20 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production. Biomed Pharmacother. 2016;82:479–488.CrossRef Zhou H, Wu J, Wang T, et al. CXCL10/CXCR20 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production. Biomed Pharmacother. 2016;82:479–488.CrossRef
21.
Zurück zum Zitat Riquelme I, Tapia O, Espinoza JA, et al. The gene expression status of the PI3K/AKT/mTOR pathway in gastric cancer tissues and cell lines. Pathol Oncol Res. 2016;22:797–805.CrossRef Riquelme I, Tapia O, Espinoza JA, et al. The gene expression status of the PI3K/AKT/mTOR pathway in gastric cancer tissues and cell lines. Pathol Oncol Res. 2016;22:797–805.CrossRef
22.
Zurück zum Zitat Yan X, Rui X, Zhang K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep. 2015;33:737–743.CrossRef Yan X, Rui X, Zhang K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep. 2015;33:737–743.CrossRef
23.
Zurück zum Zitat Deng W, Zhang Y, Gu L, et al. Heat shock protein 27 downstream of P38-PI3K/Akt signaling antagonizes melatonin-induced apoptosis of SGC-7901 gastric cancer cells. Cancer Cell Int. 2016;16:5.CrossRef Deng W, Zhang Y, Gu L, et al. Heat shock protein 27 downstream of P38-PI3K/Akt signaling antagonizes melatonin-induced apoptosis of SGC-7901 gastric cancer cells. Cancer Cell Int. 2016;16:5.CrossRef
24.
Zurück zum Zitat Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 2001;37:918–923.CrossRef Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 2001;37:918–923.CrossRef
Metadaten
Titel
Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells
verfasst von
Fei Ma
Bin Zhang
Sheqing Ji
Hongtao Hu
Ye Kong
Yawei Hua
Suxia Luo
Publikationsdatum
17.05.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05656-w

Weitere Artikel der Ausgabe 11/2019

Digestive Diseases and Sciences 11/2019 Zur Ausgabe

UNM CLINICAL CASE CONFERENCES

A Rare Site of Spread of a Common Cancer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.